108 related articles for article (PubMed ID: 24024334)
1. Effect of xixin decoction on O-linked N-acetylglucosamine glycosylation of tau proteins in rat brain with sporadic Alzheimer disease.
Diwu Y; Tian J; Shi J
J Tradit Chin Med; 2013 Jun; 33(3):367-72. PubMed ID: 24024334
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Xixin decoction on enzymes related to O-GlcNAc glycosylation of tau proteins in the brain of rats with sporadic Alzheimer's disease].
Diwu Y; Tian J; Shi J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1442-7. PubMed ID: 24144743
[TBL] [Abstract][Full Text] [Related]
3. Effect of Xixin decoction on phosphorylation toxicity at specific sites of tau protein in brains of rats with sporadic Alzheimer disease.
Diwu Y; Tian J; Shi J
J Tradit Chin Med; 2013 Dec; 33(6):787-93. PubMed ID: 24660612
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
Gong CX; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
[TBL] [Abstract][Full Text] [Related]
6. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
Ahmad W; Shabbiri K; Ahmad I
Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
[TBL] [Abstract][Full Text] [Related]
9. The emerging link between O-GlcNAc and Alzheimer disease.
Zhu Y; Shan X; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2014 Dec; 289(50):34472-81. PubMed ID: 25336656
[TBL] [Abstract][Full Text] [Related]
10. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo.
Yuzwa SA; Vocadlo DJ
Methods Mol Biol; 2017; 1523():237-248. PubMed ID: 27975253
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation of protein kinase A catalytic subunits enhances its activity: a mechanism linked to learning and memory deficits in Alzheimer's disease.
Xie S; Jin N; Gu J; Shi J; Sun J; Chu D; Zhang L; Dai CL; Gu JH; Gong CX; Iqbal K; Liu F
Aging Cell; 2016 Jun; 15(3):455-64. PubMed ID: 26840030
[TBL] [Abstract][Full Text] [Related]
12. [Effect of naringenin on learning and memory ability on model rats with Alzheimer disease].
Ma J; Yang WQ; Zha H; Yu HR
Zhong Yao Cai; 2013 Feb; 36(2):271-6. PubMed ID: 23901657
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
Lefebvre T; Ferreira S; Dupont-Wallois L; Bussière T; Dupire MJ; Delacourte A; Michalski JC; Caillet-Boudin ML
Biochim Biophys Acta; 2003 Jan; 1619(2):167-76. PubMed ID: 12527113
[TBL] [Abstract][Full Text] [Related]
14. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Yuzwa SA; Vocadlo DJ
Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
[TBL] [Abstract][Full Text] [Related]
16. Effects of Chinese herbal medicine Yinsiwei compound on spatial learning and memory ability and the ultrastructure of hippocampal neurons in a rat model of sporadic Alzheimer disease.
Diwu YC; Tian JZ; Shi J
Zhong Xi Yi Jie He Xue Bao; 2011 Feb; 9(2):209-15. PubMed ID: 21288458
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress induces transient O-GlcNAc elevation and tau dephosphorylation in SH-SY5Y cells.
Kátai E; Pál J; Poór VS; Purewal R; Miseta A; Nagy T
J Cell Mol Med; 2016 Dec; 20(12):2269-2277. PubMed ID: 27456536
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
[TBL] [Abstract][Full Text] [Related]
19. The potential role of tau protein O-glycosylation in Alzheimer's disease.
Robertson LA; Moya KL; Breen KC
J Alzheimers Dis; 2004 Oct; 6(5):489-95. PubMed ID: 15505370
[TBL] [Abstract][Full Text] [Related]
20. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.
Wang AC; Jensen EH; Rexach JE; Vinters HV; Hsieh-Wilson LC
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15120-15125. PubMed ID: 27956640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
